| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |